Fischl T, Perucca P
Epilepsy Behav Rep. 2025; 29:100727.
PMID: 40027337
PMC: 11869959.
DOI: 10.1016/j.ebr.2024.100727.
Arora A, Prakash P, Rizzo L, Blackman G, David A, Rogers J
Epilepsia. 2024; 65(12):3425-3440.
PMID: 39431966
PMC: 11647423.
DOI: 10.1111/epi.18123.
Li D, Yan X, Xing Y, Yan J, Wang J, Zhang H
Curr Neuropharmacol. 2024; 22(13):2240-2255.
PMID: 38333970
PMC: 11337692.
DOI: 10.2174/1570159X22999240131122455.
Zheng Y, Liu X, Ju M
Gen Psychiatr. 2022; 35(3):e100616.
PMID: 35866001
PMC: 9240898.
DOI: 10.1136/gpsych-2021-100616.
Brodovskaya A, Batabyal T, Shiono S, Sun H, Kapur J
Ann Neurol. 2022; 91(5):682-696.
PMID: 35226367
PMC: 9315027.
DOI: 10.1002/ana.26338.
Anticonvulsant dopamine type 2 receptor agonist activates inhibitory parvalbumin interneurons.
Brodovskaya A, Kapur J
Epilepsia. 2021; 62(9):e147-e152.
PMID: 34331457
PMC: 9299960.
DOI: 10.1111/epi.17004.
Do Psychotropic Drugs Cause Epileptic Seizures? A Review of the Available Evidence.
Detyniecki K
Curr Top Behav Neurosci. 2021; 55:267-279.
PMID: 34241816
DOI: 10.1007/7854_2021_226.
Activation of the basal ganglia and indirect pathway neurons during frontal lobe seizures.
Brodovskaya A, Shiono S, Kapur J
Brain. 2021; 144(7):2074-2091.
PMID: 33730155
PMC: 8502464.
DOI: 10.1093/brain/awab119.
Clinical features and outcome of Wilson's disease with generalized epilepsy in Chinese patients.
Wang R, Yu H, Yang G, Xu W, Xia N, Zhang Y
CNS Neurosci Ther. 2020; 26(8):842-850.
PMID: 32281751
PMC: 7366741.
DOI: 10.1111/cns.13373.
Circuits generating secondarily generalized seizures.
Brodovskaya A, Kapur J
Epilepsy Behav. 2019; 101(Pt B):106474.
PMID: 31431400
PMC: 6944760.
DOI: 10.1016/j.yebeh.2019.106474.
Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.
Weston M, Kaserer T, Wu A, Mouravlev A, Carpenter J, Snowball A
Sci Adv. 2019; 5(4):eaaw1567.
PMID: 31001591
PMC: 6469940.
DOI: 10.1126/sciadv.aaw1567.
Effects of Psychotropic Drugs on Seizure Threshold during Electroconvulsive Therapy.
Chi S, Jeong H, Lee S, Oh S, Kim S
Psychiatry Investig. 2017; 14(5):647-655.
PMID: 29042890
PMC: 5639133.
DOI: 10.4306/pi.2017.14.5.647.
Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis.
Cheung S, Hamuro Y, Mahlich J, Nakahara T, Sruamsiri R, Tsukazawa S
Clin Drug Investig. 2017; 37(6):559-569.
PMID: 28361438
PMC: 5422449.
DOI: 10.1007/s40261-017-0517-0.
Management of psychiatric and neurological comorbidities in epilepsy.
Kanner A
Nat Rev Neurol. 2016; 12(2):106-16.
PMID: 26782334
DOI: 10.1038/nrneurol.2015.243.
Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.
Bloechliger M, Ruegg S, Jick S, Meier C, Bodmer M
CNS Drugs. 2015; 29(7):591-603.
PMID: 26242478
DOI: 10.1007/s40263-015-0262-y.
Alternative Psychosis - Is it a Defined Clinical Entity?.
Banwari G, Parmar C, Kandre D
Indian J Psychol Med. 2013; 35(1):84-6.
PMID: 23833348
PMC: 3701366.
DOI: 10.4103/0253-7176.112213.
Antiepileptic drugs and other medications: what interactions may arise?.
Mani R, Pollard J
Curr Treat Options Neurol. 2009; 11(4):253-61.
PMID: 19523351
DOI: 10.1007/s11940-009-0029-1.
The alkaloid alstonine: a review of its pharmacological properties.
Elisabetsky E, Costa-Campos L
Evid Based Complement Alternat Med. 2006; 3(1):39-48.
PMID: 16550222
PMC: 1375234.
DOI: 10.1093/ecam/nek011.
An integrated neuropsychiatric approach to diagnosis and management of patients with epileptic seizures.
Hilty D, Bourgeois J, Sugden S, Chang C, Servis M, Alsaadi T
Curr Treat Options Neurol. 2005; 7(5):389-402.
PMID: 16079043
DOI: 10.1007/s11940-005-0031-1.
